Growth Metrics

Corcept Therapeutics (CORT) EBITDA (2010 - 2026)

Corcept Therapeutics recorded quarterly EBITDA of -$49.6 million in Q1 2026, down 1205.44% quarter-over-quarter from $4.5 million in Q4 2025, and down 1552.02% year-over-year from $3.4 million in Q1 2025.

Corcept Therapeutics' EBITDA history runs 17 years deep, the most recent figure standing at -$49.6 million for Q1 2026.

  • In Q1 2026, EBITDA fell 1552.02% year-over-year to -$49.6 million; the TTM figure through Mar 2026 stood at -$8.2 million (down 107.41% YoY), while the FY2025 annual figure was $44.8 million, down 67.29% from the prior year.
  • EBITDA came in at -$49.6 million for Q1 2026 at Corcept Therapeutics, down from $4.5 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $46.6 million in Q3 2024 to a low of -$49.6 million in Q1 2026.
  • A 5-year average of $20.4 million and a median of $26.7 million in 2025 frame the typical range for EBITDA.
  • Across the five-year window, EBITDA soared 98.61% in 2024 and slumped 1552.02% in 2026, its largest moves.
  • Corcept Therapeutics' EBITDA stood at $22.5 million in 2022, then soared by 40.76% to $31.7 million in 2023, then retreated by 20.23% to $25.3 million in 2024, then plunged by 82.24% to $4.5 million in 2025, then tumbled by 1205.44% to -$49.6 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered -$49.6 million, $4.5 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.63 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -14.44 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.14 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 661.60 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 201.19 Mn
10 Corcept Therapeutics 7.26 Bn 6.92 Bn 162.02 Mn -49.60 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -49.60 Mn
Dec 31, 2025 4.49 Mn
Sep 30, 2025 10.22 Mn
Jun 30, 2025 26.68 Mn
Mar 31, 2025 3.42 Mn
Dec 31, 2024 25.26 Mn
Sep 30, 2024 46.60 Mn
Jun 30, 2024 35.59 Mn
Mar 31, 2024 29.50 Mn
Dec 31, 2023 31.67 Mn
Sep 30, 2023 31.18 Mn
Jun 30, 2023 29.58 Mn
Mar 31, 2023 14.85 Mn
Dec 31, 2022 22.50 Mn
Sep 30, 2022 31.93 Mn
Jun 30, 2022 31.43 Mn
Mar 31, 2022 21.67 Mn
Dec 31, 2021 31.71 Mn
Sep 30, 2021 30.37 Mn
Jun 30, 2021 26.49 Mn
Mar 31, 2021 23.30 Mn
Dec 31, 2020 25.83 Mn
Sep 30, 2020 21.36 Mn
Jun 30, 2020 28.86 Mn
Mar 31, 2020 30.11 Mn
Dec 31, 2019 29.33 Mn
Sep 30, 2019 26.33 Mn
Jun 30, 2019 20.41 Mn
Mar 31, 2019 18.44 Mn
Dec 31, 2018 22.09 Mn
Sep 30, 2018 17.80 Mn
Jun 30, 2018 18.22 Mn
Mar 31, 2018 17.31 Mn
Dec 31, 2017 98.27 Mn
Sep 30, 2017 13.76 Mn
Jun 30, 2017 12.64 Mn
Mar 31, 2017 4.38 Mn
Dec 31, 2016 4.60 Mn
Sep 30, 2016 2.59 Mn
Jun 30, 2016 977,000.00
Mar 31, 2016 -19,000.00
Dec 31, 2015 1.65 Mn
Sep 30, 2015 102,000.00
Jun 30, 2015 -1.17 Mn
Mar 31, 2015 -4.03 Mn
Dec 31, 2014 -3.08 Mn
Sep 30, 2014 -5.10 Mn
Jun 30, 2014 -6.58 Mn
Mar 31, 2014 -12.86 Mn
Dec 31, 2013 -10.03 Mn
Sep 30, 2013 -9.74 Mn
Jun 30, 2013 -10.78 Mn
Mar 31, 2013 -10.94 Mn
Dec 31, 2012 -9.98 Mn
Sep 30, 2012 -7.67 Mn
Jun 30, 2012 -7.59 Mn
Mar 31, 2012 -11.03 Mn
Dec 31, 2011 -9.93 Mn
Sep 30, 2011 -6.44 Mn
Jun 30, 2011 -8.87 Mn
Mar 31, 2011 -7.10 Mn
Dec 31, 2010 -7.82 Mn
Sep 30, 2010 -7.11 Mn
Jun 30, 2010 -6.45 Mn